Haemonetics Is Still Undervalued, Even After The Rally

Group 1 - The focus is on producing objective, data-driven research primarily about small- to mid-cap companies, which are often overlooked by many investors [1] - Occasionally, large-cap companies are analyzed to provide a broader perspective on the equity markets [1] Group 2 - There is a beneficial long position in the shares of HAE, indicating a positive outlook on the company's stock [2]